The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 3.6% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 72%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (15 analysts) rates it none, with a mean price target of $36.
China Life Insurance Company Limited 2628.HK
Clears the common standardAn entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · China Life Insurance Company Limited, together with its subsidiaries, operates as a life insurance company in the People's Republic of China.
read at $28.44
China Life Insurance Company Limited holds its Markdown at $28.44.
- PHPhase · the trend structure carries the Markdown label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · passes the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the sellers, held for 258 days |
| Price | $28.44 |
| Valuation | 4.80 trailing · 5.42 forward price to earnings |
| Values screen | PASS |
| Beta | 0.87 |
The opportunity · what the numbers say it is worth
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Both our model and the analysts see meaningful upside from here.
| Revenue growth | -15.20% |
| Profit margin | 42.32% |
| Debt to equity | 45.08 |
| Analyst consensus | Buy · 15 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
It depends which standard you follow. There are two widely recognised ways to check whether a company is suitable for a Muslim investor, and on this company they disagree. Here is how it did on each:
Used by most halal investing apps ✗ DOES NOT PASS
The one Titan applies ✓ PASSES
Why the two disagree. They fall out over one thing only: the company’s debt. Our stricter standard measures that debt against what the company owns, and it works out too high to pass. The common standard measures the same debt against what the company is worth on the stock market, where it works out low enough to pass. Every other check, the two agree on. So in practice, most halal apps would treat this as fine to hold, while our stricter view would not — and which line you follow is between you and your scholar.
What these two standards are, and how they differ →
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
| Forward P/E | 5.4x very cheap relative to earnings |
| Trailing P/E | 4.8x very cheap relative to earnings |
| Revenue growth | -15.2% revenue is shrinking |
| Profit margin | 42.3% highly profitable on every dollar of sales |
| Return on equity | 25.5% an exceptional return on shareholder capital |
| Debt to equity | 0.45 minimal debt — a conservative balance sheet |
| Current ratio | 6.33 comfortably covers its short-term bills |
| Beta | 0.87 steadier than the market |
| Market cap | $803.8B |
The risks · The things to watch: its business and earnings are exposed to China and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Latest news · what the market is reading on 2628.HK
- › China Life Insurance Co Ltd (CILJF) Q1 2026 Earnings Call Highlights: Strong New Business ... GuruFocus.com · 30 Apr 2026
- › Asian Dividend Stocks To Enhance Your Portfolio Simply Wall St. · 14 Apr 2026
- › China Life Insurance Co Ltd (CILJF) (Full Year 2025) Earnings Call Highlights: Record Profits ... GuruFocus.com · 26 Mar 2026
- › Matthews China Fund's Strategic Moves: Spotlight on China Life Insurance Co Ltd GuruFocus.com · 4 Feb 2026
- › Does China Life (SEHK:2628) Board Shift And RMB8.5b Deal Recast Its Capital Allocation Playbook? Simply Wall St. · 30 Jan 2026
Headlines from third-party outlets, linked for reference — not our reporting, not advice.
Related securities · others in 2628.HK's space worth a look
Screened names in the same industry · explore each on its own page.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 72%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (15 analysts) rates it none, with a mean price target of $36.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $31.38 | -10.1% | · | $899 | -10.1% |
| 2 months | $27.16 | +3.8% | · | $1,038 | +3.8% |
| 3 months | $28.42 | -0.8% | · | $992 | -0.8% |
| 6 months | $28.30 | -0.4% | · | $997 | -0.4% |
| 1 year | $16.38 | +72.2% | $0.75 | $1,768 | +76.8% |
| 2 years | $10.28 | +174.4% | $1.44 | $2,884 | +188.4% |
| 3 years | $11.82 | +138.5% | $1.98 | $2,552 | +155.2% |
| 5 years | $12.31 | +129.1% | $3.51 | $2,576 | +157.6% |
Historical returns from market close data. Past performance does not guarantee future results.